S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/BVF Partners/Q3 2025

BVF Partners

Periodo: Q3 2025 · Depositato: 2025-11-14
Vedi su SEC EDGAR
AUM
$2.47B
Valore totale del portafoglio
Posizioni
46
Titoli dichiarati
Prima Posizione
KYMR
12.6% $311.4M
Var. Trimestrali
+7 / -5
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2025-11-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
KYMRKYMERA THERAPEUTICS INC$311.4M12.63%$56.60$113.51+100.5%
12.6%
RVMDREVOLUTION MEDICINES INC$185.6M7.52%$46.70$189.24+305.2%
7.5%
PTGXPROTAGONIST THERAPEUTICS INC$170.1M6.90%$66.43$131.62+98.1%
6.9%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$141.6M5.74%$7.17$18.95+164.3%
5.7%
CDTXCIDARA THERAPEUTICS INC$135.4M5.49%
5.5%
GHRSGH RESEARCH PLC$126.2M5.12%$14.30$27.01+88.9%
5.1%
MIRMMIRUM PHARMACEUTICALS INC$109.6M4.44%$73.31$125.59+71.3%
4.4%
XOMAXOMA ROYALTY CORPORATION$99.8M4.05%$38.54$43.00+11.6%
4.0%
GPCRSTRUCTURE THERAPEUTICS INC$89.7M3.64%$28.00$53.45+90.9%
3.6%
KURAKURA ONCOLOGY INC$76.3M3.09%$8.85$11.10+25.4%
3.1%
SEPNSEPTERNA INC$75.5M3.06%$18.81$34.00+80.8%
3.1%
PVLAPALVELLA THERAPEUTICS INC NE$72.8M2.95%$62.69$146.76+134.1%
3.0%
NKTRNEKTAR THERAPEUTICS$72.6M2.94%$56.90$71.04+24.9%
2.9%
ZYMEZYMEWORKS INC$67.3M2.73%$17.08$26.31+54.0%
2.7%
AXSMAXSOME THERAPEUTICS INC$59.1M2.40%$121.45$244.31+101.2%
2.4%
ACIUAC IMMUNE SA$57.3M2.32%$2.89$2.51-13.2%
2.3%
IMCRIMMUNOCORE HLDGS PLC$57.2M2.32%$36.33$32.50-10.5%
2.3%
OLMAOLEMA PHARMACEUTICALS INC$51.9M2.10%$9.79$12.64+29.1%
2.1%
TYRATYRA BIOSCIENCES INC$51.1M2.07%$13.99$30.62+118.9%
2.1%
ABVXABIVAX SA$47.4M1.92%$84.90$144.65+70.4%
1.9%
GLUEMONTE ROSA THERAPEUTICS INC$41.9M1.70%$7.41$24.21+226.7%
1.7%
FDMT4D MOLECULAR THERAPEUTICS IN$40.2M1.63%$8.69$13.00+49.6%
1.6%
STOKSTOKE THERAPEUTICS INC$38.9M1.58%$23.50$32.70+39.1%
1.6%
CGEMCULLINAN THERAPEUTICS INC$34.1M1.38%$5.93$17.63+197.3%
1.4%
CELCCELCUITY INC$32.5M1.32%$49.40$107.95+118.5%
1.3%
XNCRXENCOR INC$32.1M1.30%$11.73$15.00+27.9%
1.3%
FHTXFOGHORN THERAPEUTICS INC$25.9M1.05%$4.89$5.30+8.4%
1.1%
ANNXANNEXON INC$21.4M0.87%$3.05$5.46+79.0%
0.9%
RPTXREPARE THERAPEUTICS INC$18.2M0.74%
0.7%
AVTXAVALO THERAPEUTICS INC$17.2M0.70%$12.71$18.84+48.2%
0.7%

Attività Trimestre su Trimestre

Q3 2025 vs. Q2 2025

Nuove Posizioni (7)

TickerEmittenteNozionaleDal Deposito
NKTRNEKTAR THERAPEUTICS$72.6M+24.9%
ABVXABIVAX SA$47.4M+70.4%
STOKSTOKE THERAPEUTICS INC$38.9M+39.1%
CMPXCOMPASS THERAPEUTICS INC$16.6M
PEPGPEPGEN INC$8.8M
XFORX4 PHARMACEUTICALS INC$7.6M
IMAIMAGENEBIO INC$6.5M

Posizioni Chiuse (5)

TickerEmittenteNozionale
IONSIONIS PHARMACEUTICALS INC$75.6M
VSTMVERASTEM INC$14.1M
RAPTRAPT THERAPEUTICS INC$9.2M
IKNAIKENA ONCOLOGY INC$5.4M
OVIDOVID THERAPEUTICS INC$1.3M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
GPCRSTRUCTURE THERAPEUTICS INC$53.0M+80.9%+90.9%
CDTXCIDARA THERAPEUTICS INC$97.1M+79.8%
PVLAPALVELLA THERAPEUTICS INC NE$57.1M+66.7%+134.1%
IMCRIMMUNOCORE HLDGS PLC$25.1M+53.7%-10.5%
EPIXESSA PHARMA INC$-12.6M+33.4%
AVTXAVALO THERAPEUTICS INC$12.1M+31.8%+48.2%
KURAKURA ONCOLOGY INC$31.5M+11.1%+25.4%
SABSSAB BIOTHERAPEUTICS INC$0.3M+1.6%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
FBRXFORTE BIOSCIENCES INC$-6.6M-88.9%
CELCCELCUITY INC$-13.8M-81.0%+118.5%
AXSMAXSOME THERAPEUTICS INC$-117.3M-71.2%+101.2%
MIRMMIRUM PHARMACEUTICALS INC$-30.9M-45.8%+71.3%
PTGXPROTAGONIST THERAPEUTICS INC$-7.3M-20.2%+98.1%
RVMDREVOLUTION MEDICINES INC$2.3M-20.2%+305.2%
SEPNSEPTERNA INC$29.1M-8.7%+80.8%
ZYMEZYMEWORKS INC$13.2M-8.6%+54.0%
Torna agli Hedge Fund